You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TAS-102

Showing 1 - 25 of 531
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Sep 8, 2023

TAS-102 in Combination With Regorafenib or Fruquintinib for

Not yet recruiting
  • TAS 102
  • +3 more
  • (no location specified)
Aug 7, 2023

Colorectal Cancer Trial in Tai'an (Tas-102(Suyuan) combined with bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • Tas-102(Suyuan) combined with bevacizumab
  • Tai'an, Shandong, China
    The Second Affiliated Hospital of Shandong First Medical Univers
Oct 14, 2023

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
Sep 2, 2023

Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)

Not yet recruiting
  • Rectal Cancer
  • (no location specified)
Jul 27, 2023

Fruquintinib Combined With TAS102 for Advanced Gastric Cancer

Recruiting
  • Gastric Cancer
  • Fruquintinib, TAS102
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 22, 2023

Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester

Active, not recruiting
Has Results
  • Cholangiocarcinoma
  • +6 more
  • Laboratory Biomarker Analysis
  • Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
  • Scottsdale, Arizona
  • +1 more
Jan 4, 2023

Called STAR-T to Learn More About Sequential Treatment With

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Regorafenib (BAY73-4506, Stivarga®)
  • +2 more
  • Whippany, New Jersey
    Many locations
Apr 21, 2023

Rectal Adenocarcinoma, Recurrent Rectal Carcinoma, Stage IV Rectal Cancer AJCC v7 Trial in Scottsdale, Rochester (other,

Completed
  • Rectal Adenocarcinoma
  • +4 more
  • Quality-of-Life Assessment
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jan 3, 2023

Colon Cancer, Rectal Cancer Trial in United States (TAS-102, oxaliplatin, irinotecan with bevacizumab)

Not yet recruiting
  • Colon Cancer
  • Rectal Cancer
  • TAS-102, oxaliplatin, irinotecan with bevacizumab
  • Elizabeth, New Jersey
  • +6 more
Apr 7, 2023

Refractory Metastatic Colorectal Cancer Trial in Berlin (Radiofrequency electromagnetic field treatment)

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • Radiofrequency electromagnetic field treatment
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Aug 3, 2023

Metastatic Colorectal Cancer Trial in Madison (Liposomal irinotecan, TAS102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Liposomal irinotecan
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
May 2, 2023

Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Trifluridine/Tipiracil)

Recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 24, 2023

Metastatic Colorectal Cancer Trial in Guangzhou (fruquintinib plus TAS-102)

Recruiting
  • Metastatic Colorectal Cancer
  • fruquintinib plus TAS-102
  • Guangzhou, Guangdong, China
    the first affiliated hospital of Sun Yat-sen University
Aug 17, 2022

Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma, Refractory Colorectal Carcinoma Trial in Livingston, New Brunswick

Recruiting
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Elizabeth, New Jersey
  • +5 more
Oct 17, 2022

Pancreatic Tumors Trial in Guangzhou (Surufatinib, TAS-102)

Not yet recruiting
  • Pancreatic Neoplasms
  • Guangzhou, Guangdong, China
    Cancer center of SunYat-sen University
Jul 28, 2022

Immunotherapy, Colorectal Cancer Trial in Fuzhou (Tislelizumab, bevacizumab, TAS-102)

Recruiting
  • Immunotherapy
  • Colorectal Cancer
  • Fuzhou, Fujian, China
  • +1 more
Jul 20, 2022

Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

Recruiting
  • Colorectal Adenocarcinoma
  • +13 more
  • Nanoliposomal Irinotecan
  • Trifluridine and Tipiracil Hydrochloride
  • Atlanta, Georgia
  • +2 more
Jan 6, 2023

Colorectal Cancer Trial in Houston (TAS-102)

Recruiting
  • Colorectal Cancer
  • TAS-102
  • Houston, Texas
    MD Anderson Cancer Center
Jun 7, 2022

Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)

Completed
  • Colon Cancer
  • +2 more
  • Tas-102
  • SIR-Sphere
  • San Francisco, California
    University of California San Francisco
Jul 28, 2022

Advanced Colorectal Cancer Trial (Bevacizumab combined with Oxaliplatin and TAS-102)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Bevacizumab combined with Oxaliplatin and TAS-102
  • (no location specified)
May 16, 2022

Pancreas Cancer Trial in Hong Kong (TAS 102)

Recruiting
  • Pancreas Cancer
  • TAS 102
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, HKU
Jul 13, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +5 more
  • Trastuzumab
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 31, 2023

Trifluridine/Tipiracil Plus Bevacizumab Versus

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
May 11, 2023

Bladder Cancer Trial in Fairway, Kansas City (TAS 102)

Recruiting
  • Bladder Cancer
  • TAS 102
  • Fairway, Kansas
  • +1 more
Mar 9, 2022